Generic Database of Very Low Birth Weight Infants
Launched by NICHD NEONATAL RESEARCH NETWORK · Jun 19, 2003
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Generic Database of Very Low Birth Weight Infants is a study aimed at understanding the health outcomes of infants who are born with very low birth weight, typically weighing between 401 and 1000 grams and born before 29 weeks of pregnancy. This trial collects important information about these infants and their mothers, including treatments received and how the infants are doing after birth. The goal is to analyze this data to find patterns that can help improve care for these vulnerable babies in future research studies.
To be eligible for this study, infants must be born at specific research centers and meet the weight and age criteria mentioned above. This means that if your baby is born very early or is very small, they might qualify to participate. If enrolled, you can expect that your baby's health information will be monitored and recorded, which could contribute to valuable insights for improving neonatal care. It’s also important to know that if your baby is part of other related studies, they might still be included in this database even if they don't meet the usual weight and age requirements.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Infants inborn at NICHD NRN centers that are:
- • 401-1000 grams birth weight, and/or
- • 20 0/7 to 28 6/7 weeks (\<29 weeks) gestational age
- • Infants enrolled in one or more additional NICHD NRN interventional trials or time-limited observational studies. For infants that do not meet the inclusion criteria above, inclusion and exclusion criteria for the Generic Database are determined by the criteria for the additional trial(s). In these cases, infants that are larger than 1,000 grams and/or older than 29 weeks may be included in the GDB.
- Exclusion Criteria:
- • Infants \>1,000 grams birth weight and/or \>29 weeks gestational age
- • Note: These inclusion criteria were changed as of 1/1/2008. Prior to this date, all infants with birth weights between 401 and 1500 grams who are admitted to NRN NICUs within 14 days of birth were included in the database.
About Nichd Neonatal Research Network
The NICHD Neonatal Research Network (NNR) is a premier collaborative research initiative sponsored by the National Institute of Child Health and Human Development (NICHD). It focuses on advancing the understanding and treatment of neonatal conditions through rigorous clinical trials and studies. By uniting leading medical centers and researchers, the NNR aims to improve neonatal health outcomes, enhance care practices, and contribute to evidence-based guidelines. The network emphasizes multidisciplinary approaches, innovative methodologies, and patient-centered research, making significant strides in the field of neonatal care and contributing valuable insights to pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Palo Alto, California, United States
Iowa City, Iowa, United States
Kansas City, Missouri, United States
Atlanta, Georgia, United States
Rochester, New York, United States
Durham, North Carolina, United States
Detroit, Michigan, United States
Palo Alto, California, United States
New Haven, Connecticut, United States
Miami, Florida, United States
Indianapolis, Indiana, United States
Cambridge, Massachusetts, United States
Albuquerque, New Mexico, United States
Durham, North Carolina, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Providence, Rhode Island, United States
Memphis, Tennessee, United States
Dallas, Texas, United States
Houston, Texas, United States
San Diego, California, United States
Burlington, Vermont, United States
Boston, Massachusetts, United States
Washington, District Of Columbia, United States
Los Angeles, California, United States
Columbus, Ohio, United States
Dallas, Texas, United States
Salt Lake City, Utah, United States
Philadelphia, Pennsylvania, United States
San Diego, California, United States
Chicago, Illinois, United States
Jackson, Mississippi, United States
Patients applied
Trial Officials
Abbot R Laptook, MD
Principal Investigator
Brown University, Women & Infants Hospital of Rhode Island
Anna Maria Hibbs, MD, MSCE, FAAP
Principal Investigator
Case Western Reserve University, Rainbow Babies and Children's Hospital
C. Michael Cotten, MD
Principal Investigator
Duke University
Ravi M Patel, MD, MSc
Study Chair
Emory University
Abhik Das, PhD
Principal Investigator
RTI International
Krisa P Van Meurs, MD
Principal Investigator
Stanford University
Stephanie Merhar, MD MS
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Waldemar A Carlo, MD
Principal Investigator
University of Alabama at Birmingham
Tarah Colaizy, MD, MPH
Principal Investigator
University of Iowa
Kristi L Watterberg, MD
Principal Investigator
University of New Mexico
Myra Wyckoff, MD
Principal Investigator
University of Texas, Southwestern Medical Center at Dallas
Jon E Tyson, MD MPH
Principal Investigator
The University of Texas Health Science Center, Houston
Sara DeMauro, MD, MSCE
Principal Investigator
University of Pennsylvania
Carl D'Angio, MD
Principal Investigator
University of Rochester
Pablo Sanchez, MD
Principal Investigator
Research Institute at Nationwide Children's Hospital
Robin Ohls, MD
Principal Investigator
University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials